Evoke abstract accepted at AMCP meeting

Evoke Pharma announced that its abstract entitled "Real-World Healthcare Resource Utilization of Patients Treated with Metoclopramide Nasal for Diabetic Gastroparesis DGP will be presented at the Academy of Managed Care Pharmacy AMCP annual meeting taking place in San Antonio, TX from March 21-24. Lead author, Dr. David C. Kunkel, Gastroenterologist and Associate Professor of Medicine at UC San Diego Health, emphasized the challenges faced by patients with gastroparesis who have limited treatment options and often experience flare-ups. "The positive response to the clinical utilization of GIMOTI gathered from patients through our studies and surveys is highly encouraging and continues to emphasize the major treatment gap GIMOTI fills every day for people suffering from diabetic gastroparesis. Patients and health care providers need new treatment options and are eager to learn whether these options can improve their symptoms and reduce their need to visit the ER or take more invasive steps to improve their condition. The presentation at the AMCP meeting will show how GIMOTI utilization is supporting the continuum of care for patients," commented Chris Quesenberry, Chief Commercial Officer for GIMOTI.